Skip to content

The Application Value of Cardiopulmonary Exercise Test Combined with Noninvasive Cardiac Output Monitoring in Cardiac Rehabilitation of Patients with Chronic Heart Failure

The Application Value of Cardiopulmonary Exercise Test Combined with Noninvasive Cardiac Output Monitoring in Cardiac Rehabilitation of Patients with Chronic Heart Failure

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600122165
Enrollment
Unknown
Registered
2026-04-09
Start date
2026-04-10
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Heart Failure (CHF)

Interventions

Experimental Group:based on the combined assessment results of cardiopulmonary exercise testing (CPET) and non-invasive cardiac output monitoring
Control Group :Formulate cardiac rehabilitation programs using cardiopulmonary exercise testing (CPET) assessment

Sponsors

Emergency General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 75 years; 2. Meeting the diagnostic criteria specified in ; 3. NYHA functional classification Class II-III; 4. Left ventricular ejection fraction (LVEF) >= 40%; 5. Stable condition (no acute episode of heart failure within the past 1 month); 6. Exercise rehabilitation training deemed acceptable based on physical fitness assessment, with written informed consent obtained from the patient and their family members.

Exclusion criteria

Exclusion criteria: 1. Acute myocardial infarction (within 1 week) and unstable angina pectoris; 2. Severe arrhythmias (ventricular tachycardia, atrial fibrillation with rapid ventricular response) and acute heart failure exacerbation; 3. Sustained blood pressure > 180/110 mmHg; 4. Severe anemia (Hb < 90 g/L) and uncorrected electrolyte disturbances; 5. Severe pulmonary disease (FEV1 < 50% of predicted value); 6. Cognitive impairment leading to inability to cooperate with rehabilitation training; 7. Cancer patients with an expected survival time of < 6 months.

Design outcomes

Primary

MeasureTime frame
Parameters measured by non-invasive cardiac output monitoring (ICG): CO, CI, SV, SVR, ICON;Parameters measured by cardiopulmonary exercise testing (CPET): VO?peak, AT, VE/VCO?, etc.;

Secondary

MeasureTime frame
Parameters measured by echocardiography: LVEF, LAD, LVEDD, LVESD;Parameters measured by the 6 Minute Walk Test (6MWT): 6MWD, Mets, HRmax;Incidence of adverse events: abnormal hypertension, heart failure readmission, angina pectoris, myocardial infarction, etc.;Improvement rate of quality of life: Minnesota Living with Heart Failure Questionnaire (MLHFQ);New York Heart Association (NYHA) functional classification ?;

Countries

China

Contacts

Public ContactZhang Qi

Emergency General Hospital

fengyeqiqi9999@163.com+86 10 87935352

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026